Identification of significantly mutated regions across cancer types highlights a rich landscape of functional molecular alterations

Nature Genetics

Volumn 48, Issue 2, 2016, Pages 117-125

  Araya, Carlos L ^a   Cenik, Can ^a   Reuter, Jason A ^a   Kiss, Gert ^b   Pande, Vijay S ^b   Snyder, Michael P ^a   Greenleaf, William J ^a,b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTION FACTOR;

ARTICLE; BINDING SITE; BIOPHYSICS; CANCER RESEARCH; GENE MUTATION; GENETIC IDENTIFICATION; GENETIC PARAMETERS; HUMAN; MOLECULAR GENETICS; MUTATION RATE; PRIORITY JOURNAL; SIGNIFICANTLY MUTATED REGION; SIMULATION; UNTRANSLATED REGION; GENETICS; MUTATION; NEOPLASM;

HUMANS; MUTATION; NEOPLASMS;

EID: 84956615603     PISSN: 10614036     EISSN: 15461718     Source Type: Journal    
DOI: 10.1038/ng.3471     Document Type: Article

References (81)

1. Hodis E., et al A landscape of driver mutations in melanoma. Cell 150, 251-263 (2012
2. Huang F.W., et al. Highly recurrent TERT promoter mutations in human melanoma. Science 339, 957-959 (2013
3. Alexandrov L.B., et al. Signatures of mutational processes in human cancer. Nature 500, 415-421 (2013
4. Lawrence M.S., et al. Mutational heterogeneity in cancer and the search for new cancer-Associated genes. Nature 499, 214-218 (2013
5. Lawrence M.S., et al. Discovery and saturation analysis of cancer genes across 21 tumour types. Nature 505, 495-501 (2014
6. Ding, L., Wendl, M.C., McMichael, J.F., & Raphael, B.J. Expanding the computational toolbox for mining cancer genomes. Nat. Rev. Genet. 15, 556-570 (2014
7. Davies H., et al. Mutations of the BRAF gene in human cancer. Nature 417, 949-954 (2002
8. Parsons D.W., et al. An integrated genomic analysis of human glioblastoma multiforme. Science 321, 1807-1812 (2008
9. Kane, D.P., & Shcherbakova, P.V A common cancer-Associated DNA polymerase e mutation causes an exceptionally strong mutator phenotype, indicating fidelity defects distinct from loss of proofreading. Cancer Res. 74, 1895-1901 (2014
10. Dees N.D., et al. MuSiC: identifying mutational significance in cancer genomes. Genome Res. 22, 1589-1598 (2012
11. Tamborero, D., Gonzalez-Perez, A., & Lopez-Bigas, N. OncodriveCLUST: exploiting the positional clustering of somatic mutations to identify cancer genes. Bioinformatics 29, 2238-2244 (2013
12. Porta-Pardo, E., & Godzik, A. e-Driver: a novel method to identify protein regions driving cancer. Bioinformatics 30, 3109-3114 (2014
13. Schnall-Levin, M., Zhao, Y., Perrimon, N., & Berger, B. Conserved microRNA targeting in Drosophila is as widespread in coding regions as in 3' UTRs. Proc. Natl. Acad. Sci. USA 107, 15751-15756 (2010
14. Cenik C., et al. Genome analysis reveals interplay between 5' UTR introns and nuclear mRNA export for secretory and mitochondrial genes. PLoS Genet. 7, e1001366 (2011
15. Stergachis A.B., et al. Exonic transcription factor binding directs codon choice and affects protein evolution. Science 342, 1367-1372 (2013
16. Wolfe A.L., et al. RNA G-quadruplexes cause eIF4A-dependent oncogene translation in cancer. Nature 513, 65-70 (2014
17. Xiong H.Y., et al. RNA splicing. The human splicing code reveals new insights into the genetic determinants of disease. Science 347, 1254806 (2015
18. Gerstberger, S., Hafner, M., & Tuschl, T A census of human RNA-binding proteins. Nat. Rev. Genet. 15, 829-845 (2014
19. ENCODE Project Consortium. An integrated encyclopedia of DNA elements in the human genome. Nature 489 57-74 (2012
20. Weinhold, N., Jacobsen, A., Schultz, N., Sander, C., & Lee, W. Genome-wide analysis of noncoding regulatory mutations in cancer. Nat. Genet. 46, 1160-1165 (2014
21. Fredriksson, N.J., Ny, L., Nilsson, J.A., & Larsson, E. Systematic analysis of noncoding somatic mutations and gene expression alterations across 14 tumor types. Nat. Genet. 46, 1258-1263 (2014
22. Supek, F., Miñana, B., Valcárcel, J., Gabaldón, T., & Lehner, B. Synonymous mutations frequently act as driver mutations in human cancers. Cell 156, 1324-1335 (2014
23. Melton, C., Reuter, J.A., Spacek, D.V., & Snyder, M. Recurrent somatic mutations in regulatory regions of human cancer genomes. Nat. Genet. 47, 710-716 (2015
24. Hofree, M., Shen, J.P., Carter, H., Gross, A., & Ideker, T. Network-based stratification of tumor mutations. Nat. Methods 10, 1108-1115 (2013
25. Leiserson M.D.M., et al. Pan-cancer network analysis identifies combinations of rare somatic mutations across pathways and protein complexes. Nat. Genet. 47, 106-114 (2015
26. Araya C.L., et al. Regulatory analysis of the C. elegans genome with spatiotemporal resolution. Nature 512, 400-405 (2014
27. Stergachis A.B., et al. Conservation of trans-Acting circuitry during mammalian regulatory evolution. Nature 515, 365-370 (2014
28. Roadmap Epigenomics Consortium. Integrative analysis of 111 reference human epigenomes. Nature 518 317-330 (2015
29. Cingolani, P., et al A program for annotating and predicting the effects of single nucleotide polymorphisms, SnpEff: SNPs in the genome of Drosophila melanogaster strain w1118; iso-2; iso-3. Fly (Austin) 6, 80-92 (2012
30. Martin, E., Kriegel, H.P., Jörg, S., & Xiaowei, X A density-based algorithm for discovering clusters in large spatial databases with noise. KDD 96, 226-231 (1996
31. Futreal P.A., et al A census of human cancer genes. Nat. Rev. Cancer 4, 177-183 (2004
32. Santarius, T., Shipley, J., Brewer, D., Stratton, M.R., & Cooper, C.S A census of amplified and overexpressed human cancer genes. Nat. Rev. Cancer 10, 59-64 (2010
33. Malhotra A., et al. Breakpoint profiling of 64 cancer genomes reveals numerous complex rearrangements spawned by homology-independent mechanisms. Genome Res. 23, 762-776 (2013
34. Jåger D., et al. Identification of a tissue-specific putative transcription factor in breast tissue by serological screening of a breast cancer library. Cancer Res. 61, 2055-2061 (2001
35. Mei Y.-P., et al. Small nucleolar RNA 42 acts as an oncogene in lung tumorigenesis. Oncogene 31, 2794-2804 (2012
36. Okugawa Y. et al. Clinical significance of SNORA42 as an oncogene and a prognostic biomarker in colorectal cancer. Gut http://dx.doi.org/10.1136/gutjnl-2015-309359 (15 October 2015
37. Budinska, E., et al. Gene expression patterns unveil a new level of molecular heterogeneity in colorectal cancer. J. Pathol. 231, 63-76 (2013
38. Uhlén M., et al. Proteomics. Tissue-based map of the human proteome. Science 347, 1260419 (2015
39. Vejnar, C.E., & Zdobnov, E.M. MiRmap: comprehensive prediction of microRNA target repression strength. Nucleic Acids Res. 40, 11673-11683 (2012
40. Lara, R., Seckl, M.J., & Pardo, O.E. The p90 RSK family members: common functions and isoform specificity. Cancer Res. 73, 5301-5308 (2013
41. Li J., et al. TCPA: a resource for cancer functional proteomics data. Nat. Methods 10, 1046-1047 (2013
42. Samuels Y., et al. High frequency of mutations of the PIK3CA gene in human cancers. Science 304, 554 (2004
43. Thorpe, L.M., Yuzugullu, H., & Zhao, J.J. PI3K in cancer: divergent roles of isoforms, modes of activation and therapeutic targeting. Nat. Rev. Cancer 15, 7-24 (2015
44. Cancer Genome Atlas Research Network. Integrated genomic characterization of endometrial carcinoma. Nature 497 67-73 (2013
45. Miled N., et al. Mechanism of two classes of cancer mutations in the phosphoinositide 3-kinase catalytic subunit. Science 317, 239-242 (2007
46. Huang C.-H., et al. The structure of a human p110α/p85α complex elucidates the effects of oncogenic PI3Kα mutations. Science 318, 1744-1748 (2007
47. Gkeka P., et al. Investigating the structure and dynamics of the PIK3CA wild-Type and H1047R oncogenic mutant. PLoS Comput. Biol. 10, e1003895 (2014
48. Burke, J.E., Perisic, O., Masson, G.R., Vadas, O., & Williams, R.L. Oncogenic mutations mimic and enhance dynamic events in the natural activation of phosphoinositide 3-kinase p110α (PIK3CA). Proc. Natl. Acad. Sci. USA 109, 15259-15264 (2012
49. Haling J.R., et al. Structure of the BRAF-MEK complex reveals a kinase activity independent role for BRAF in MAPK signaling. Cancer Cell 26, 402-413 (2014
50. Kar, G., Gursoy, A., & Keskin, O. Human cancer protein-protein interaction network: a structural perspective. PLoS Comput. Biol. 5, e1000601 (2009
51. Ghersi, D., & Singh, M. Interaction-based discovery of functionally important genes in cancers. Nucleic Acids Res. 42, e18 (2014
52. Cheng F., et al. Studying tumorigenesis through network evolution and somatic mutational perturbations in the cancer interactome. Mol. Biol. Evol. 31, 2156-2169 (2014
53. Barbieri, C.E., et al. Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer. Nat. Genet. 44, 685-689 (2012
54. Fleming, N.I., et al. SMAD2, SMAD3 and SMAD4 mutations in colorectal cancer. Cancer Res. 73, 725-735 (2013
55. Yuen, B.T.K., & Knoepfler, P.S. Histone H3.3 mutations: a variant path to cancer. Cancer Cell 24, 567-574 (2013
56. Hornbeck P.V., et al. PhosphoSitePlus: a comprehensive resource for investigating the structure and function of experimentally determined post-Translational modifications in man and mouse. Nucleic Acids Res. 40, D261-D270 (2012
57. Cheng K.W., et al. The RAB25 small GTPase determines aggressiveness of ovarian and breast cancers. Nat. Med. 10, 1251-1256 (2004
58. Zhang J., et al. Overexpression of Rab25 contributes to metastasis of bladder cancer through induction of epithelial-mesenchymal transition and activation of Akt/GSK-3β/Snail signaling. Carcinogenesis 34, 2401-2408 (2013
59. DeNicola G.M., et al. Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis. Nature 475, 106-109 (2011
60. Ji Q., et al. Selective loss of AKR1C1 and AKR1C2 in breast cancer and their potential effect on progesterone signaling. Cancer Res. 64, 7610-7617 (2004
61. Stanbrough M., et al. Increased expression of genes converting adrenal androgens to testosterone in androgen-independent prostate cancer. Cancer Res. 66, 2815-2825 (2006
62. Rižner, T.L., Š;muc, T., Rupreht, R., Šinkovec, J., & Penning, T.M. AKR1C1 and AKR1C3 may determine progesterone and estrogen ratios in endometrial cancer. Mol. Cell. Endocrinol. 248, 126-135 (2006
63. Zhao, L., & Vogt, P.K. Helical domain and kinase domain mutations in p110α of phosphatidylinositol 3-kinase induce gain of function by different mechanisms. Proc. Natl. Acad. Sci. USA 105, 2652-2657 (2008
64. Wu X., et al. Activation of diverse signalling pathways by oncogenic PIK3CA mutations. Nat. Commun. 5, 4961 (2014
65. Puente X.S., et al. Non-coding recurrent mutations in chronic lymphocytic leukaemia. Nature 526, 519-524 (2015
66. Supek, F., & Lehner, B. Differential DNA mismatch repair underlies mutation rate variation across the human genome. Nature 521, 81-84 (2015
67. Reijns M.A.M., et al. Lagging-strand replication shapes the mutational landscape of the genome. Nature 518, 502-506 (2015
68. Lord, C.J., & Ashworth, A. The DNA damage response and cancer therapy. Nature 481, 287-294 (2012
69. Roberts S.A., et al. An APOBEC cytidine deaminase mutagenesis pattern is widespread in human cancers. Nat. Genet. 45, 970-976 (2013
70. Polak P., et al. Cell-of-origin chromatin organization shapes the mutational landscape of cancer. Nature 518, 360-364 (2015
71. Araya, C.L., et al A fundamental protein property, thermodynamic stability, revealed solely from large-scale measurements of protein function. Proc. Natl. Acad. Sci. USA 109, 16858-16863 (2012
72. Buenrostro J.D., et al. Quantitative analysis of RNA-protein interactions on a massively parallel array reveals biophysical and evolutionary landscapes. Nat. Biotechnol. 32, 562-568 (2014
73. Guenther U.-P., et al. Hidden specificity in an apparently nonspecific RNA-binding protein. Nature 502, 385-388 (2013
74. Oliphant, T.E. Python for scientific computing. Comput. Sci. Eng. 9, 10-20 (2007
75. Millman, K.J., & Aivazis, M. Python for scientists and engineers. Comput. Sci. Eng. 13, 9-12 (2011
76. McKinney W. in Proc. 9th Python Sci. Conf. (eds. van der Walt, S., & Millman, J.) 51-56 2010). ISBN-13: 978-1-4583-4619-3
77. Dale, R.K., Pedersen, B.S., & Quinlan, A.R. Pybedtools: a flexible Python library for manipulating genomic datasets and annotations. Bioinformatics 27, 3423-3424 (2011
78. Van der Walt, S., Colbert, S.C., & Varoquaux, G. The NumPy Array: a structure for efficient numerical computation. Comput. Sci. Eng. 13, 22-30 (2011
79. Pedregosa F., et al. Scikit-learn: machine learning in Python. J. Mach. Learn. Res. 12, 2825-2830 (2011
80. Cock P.J.A., et al. Biopython: freely available Python tools for computational molecular biology and bioinformatics. Bioinformatics 25, 1422-1423 (2009
81. Boyle A.P., et al. Comparative analysis of regulatory information and circuits across distant species. Nature 512, 453-456 (2014